肺癌筛查中主动脉瓣钙化与冠状动脉钙化联合预测心血管疾病死亡
研究纳入纽约州8618名吸烟者低剂量CT肺癌筛查的前瞻性队列,截止2009年12月643例死亡中169例死于心血管疾病,中位随访96.4个月。视觉评估主动脉瓣钙化(AVC)的有无,冠状动脉钙化(CAC)按0-12分序数评分分为0、1-3、4-12三组。校正CAC分组和其他危险因素后,AVC>0且CAC≥4者心血管疾病死亡风险是AVC=0且CAC<4组的2.35倍(95%CI 1.57-3.50)。
要点
- 低剂量CT肺癌筛查时视觉评估的主动脉瓣钙化(AVC>0)是心血管疾病死亡的显著预测因子(校正HR=1.39,p=0.045)。
- AVC>0且CAC≥4者较AVC=0且CAC<4者心血管疾病死亡风险增加,校正HR=2.35(95%CI 1.57-3.50)。
- AVC患病率随CAC分组严重程度增加而显著升高(p<0.0001),两者相关系数r=0.29、ρ=0.32、τB=0.28(均p<0.0001)。
核心结论
- 低剂量CT上发现的主动脉瓣钙化是未来心血管疾病死亡的显著预测因子,尤其对序数CAC评分≥4者。
研究设计与样本
- 前瞻性队列研究,纳入2000年6月至2005年12月纽约州低剂量CT肺癌筛查的8618名吸烟者,截至2009年12月死亡643例中169例死于心血管疾病,中位随访96.4个月;视觉评估AVC有无,CAC序数评分0-12分为0、1-3、4-12三组;采用Cox比例风险回归分析。
关键影像表现/征象
- AVC患病率随CAC分组严重程度增加而显著升高(p<0.0001)。
- AVC与CAC显著相关,Pearson r=0.29、Spearman ρ=0.32、Kendall τB=0.28(均p<0.0001)。
诊断标准与关键数值
- AVC视觉评估为无(AVC=0)或有(AVC>0)。
- CAC序数评分0-12分,分为三个验证的预后类别:0、1-3、4-12。
- 单独分析时,校正后CAC的HR=1.57(p=0.04),AVC的HR=1.39(p=0.045),均为心血管疾病死亡的显著预测因子。
- AVC>0且CAC≥4相比AVC=0且CAC<4的参照组,校正其他危险因素后HR=2.35(95%CI 1.57-3.50)。
临床应用与阅片要点
- 低剂量CT肺癌筛查时除评估CAC外,可同时视觉评估主动脉瓣钙化有无,以辅助识别心血管疾病死亡高风险者。
- AVC>0且CAC≥4者心血管疾病死亡风险较AVC=0且CAC<4者更高,阅片报告时可提示临床关注。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Smoking is a major risk factor for both cardiovascular disease (CVD) and lung cancer. Aortic valve calcification (AVC) and coronary artery calcification (CAC) are both due to atherosclerotic disease. We aim to investigate whether AVC on low-dose CT (LDCT) predicts death from CVD in smokers beyond that provided by CAC.
METHODS: We reviewed a prospective cohort of 8618 smokers enrolled in LDCT screening for lung cancer in New York State between June 2000 and December 2005. As of December 2009, 169 of the 643 deaths were due to CVD; median follow-up time was 96.4 months. Visual AVC was assessed as being absent (AVC = 0) or present (AVC > 0). CAC ordinal scores of 0-12 were categorized into three validated prognostic categories (0, 1-3, and 4-12). Cox proportional hazards regression analysis was used to assess whether AVC > 0 increased the risk of CVD death, after adjustment for CAC categories and other risk factors.
RESULTS: The prevalence of AVC significantly increased (p < 0.0001) with the increasing severity of the CAC categories; Pearson, Spearman, and Kendall's correlation coefficients showed a significant correlation between AVC and CAC with r = 0.29, ρ = 0.32, and τB = 0.28 (all p values < 0.0001), respectively. CAC and AVC were significant predictors of CVD death when considered alone using multivariable Cox regression analysis (adjusted HR of CAC = 1.57, p = 0.04; adjusted HR of AVC = 1.39, p = 0.045). When AVC > 0 and CAC ≥ 4, the hazard ratio was 2.35 (95%CI 1.57-3.50) compared with the reference group of AVC = 0 and CAC < 4, when adjusted for other risk factors.
CONCLUSIONS: The presence of AVC identified on LDCT is a significant predictor of future CVD death, particularly for those with ordinal CAC score ≥ 4.
KEY POINTS: • Aortic valve calcification (AVC) and coronary artery calcification (CAC) are both due to atherosclerotic disease. The prevalence of AVC in lung cancer screening cohort significantly increased with the increasing severity of CAC. • CAC and AVC were significant predictors of cardiovascular disease (CVD) death when considered alone. Participants who underwent lung cancer screening with AVC > 0 and CAC ≥ 4 had more than a 2-fold increased risk of CVD death than the group with AVC = 0 and CAC < 4, when adjusted for other risk factors.
引用
- Zhu Y, Yip R, Shemesh J, et al. Combined aortic valve and coronary artery calcifications in lung cancer screening as predictors of death from cardiovascular disease. Eur Radiol. 2020. PMID: 32725329. doi:10.1007/s00330-020-07049-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。